PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för melphalan. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

12 hits

Bibliografisk träff 2008-07-01

Chromosome aberrations and telomere length modulation in bone marrow and spleen cells of melphalan-treated p53+/- mice.

Sgura A, De Amicis A, Stronati L, Cinelli S, Pacchierotti F, Tanzarella C.

Environ Mol Mutagen · research support, non-u.s. gov't; journal article · DOI 10.1002/em.20405

Bibliografisk träff 2002-01-30

Covalent binding of nitrogen mustards to the cysteine-34 residue in human serum albumin.

Noort D, Hulst AG, Jansen R.

Arch Toxicol · research support, non-u.s. gov't; journal article · DOI 10.1007/s00204-001-0318-2

Bibliografisk träff 2001-09-01

Cytotoxicity and effect on collagen biosynthesis of proline analogue of melphalan as a prolidase-convertible prodrug in cultured human skin fibroblasts.

Chrzanowski K, Bielawska A, Bielawski K, Wołczyński S, Pałka J.

Farmaco · journal article · DOI 10.1016/s0014-827x(01)01130-2

Bibliografisk träff 2000-08-01

Phenyl sulfur mustard derivatives of distamycin A.

Cozzi P, Beria I, Caldarelli M, Capolongo L, Geroni C, Mazzini S, Ragg E.

Bioorg Med Chem Lett · journal article · DOI 10.1016/s0960-894x(00)00295-x

Bibliografisk träff 2000-01-01

Enhanced cytogenetic and antitumor effects by 9-nitrocamptothecin and antineoplastics.

Karaberis E, Mourelatos D.

Teratog Carcinog Mutagen · journal article · DOI 10.1002/(sici)1520-6866(2000)20:3<141::aid-tcm5>3.0.co;2-d

Bibliografisk träff 1997-05-01

Evaluation of the porphyrinogenic risk of antineoplastics.

Cochón AC, Aldonatti C, San Martín de Viale LC, Wainstok de Calmanovici R.

J Appl Toxicol · research support, non-u.s. gov't; journal article · DOI 10.1002/(sici)1099-1263(199705)17:3<171::aid-jat419>3.0.co;2-a

Bibliografisk träff 1997-01-01

Cytotoxic activity of cyclosporin A and [3-keto-Bmt1]-[Val2]-cyclosporin (SDZ PSC 833) on tumour cells from patients with haematological malignancies.

Martinsson P, Nygren P, Fridborg H, Nilsson K, Kristensen J, Larsson R.

Eur J Clin Pharmacol · journal article · DOI 10.1007/s002280050274

Bibliografisk träff 1996-12-01

Kinetics of the reaction of a potential chemopreventive agent, 2,6-dithiopurine, and its major metabolite, 2,6-dithiouric acid, with multiple classes of electrophilic toxicants.

Qing WG, Powell KL, MacLeod MC.

Chem Res Toxicol · research support, non-u.s. gov't; journal article · DOI 10.1021/tx960088n

Bibliografisk träff 1995-12-01

Dominant lethal and heritable translocation tests with chlorambucil and melphalan in male mice.

Generoso WM, Witt KL, Cain KT, Hughes L, Cacheiro NL, Lockhart AM, Shelby MD.

Mutat Res · journal article · DOI 10.1016/0165-1218(95)90052-7

Bibliografisk träff 1995-07-01

Characterization of alkylating versus intercalating anticancer drug-induced effects on cell survival, cell cycle kinetic and morphonuclear pattern of three neoplastic cells lines growing in vitro.

Pauwels O, Kiss R, Pasteels JL, Atassi G.

Pharm Res · research support, non-u.s. gov't; journal article · DOI 10.1023/a:1016258431063

Bibliografisk träff 1995-06-01

Effect of alkyl-N-purine DNA glycosylase overexpression on cellular resistance to bifunctional alkylating agents.

Bramson J, O'Connor T, Panasci L.

Biochem Pharmacol · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1016/0006-2952(95)00114-f

Bibliografisk träff 1979-05-01

Lymphocyte transformation studies in drug hypersensitivity.

Warrington RJ, Tse KS.

Can Med Assoc J · research-article; journal article